Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD (D.N.J. 2020)

BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD (D.N.J. 2020)

Docket		Date Filed	2020-05-01
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Stanley R. Chesler
Jury Demand	None	Referred To	Cathy L. Waldor
Patents	10,251,895; 10,426,787; 10,478,502; 8,809,307
Link to Docket	External link to docket

Details for BAUSCH HEALTH IRELAND LIMITED v. PADAGIS ISRAEL PHARMACEUTICALS LTD (D.N.J. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2022-05-20	144	Order on Motion for Summary Judgment	Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”) and 10,426,787 (the “’787 patent,” and together…States Patent Application No. 15/173,961 ultimately issued as the ’895 patent. United States Patent Application…together with the ’895 patent, the “Combination Patents”). For the reasons that follow, Plaintiffs’ motion…903,785 ultimately issued as the ’787 patent. The Combination Patents have the same inventors, both claim…8362 Patent Application No. 15/903,785, which was filed on June 18, 2015, and the two patents have	External link to document
2022-09-21	196	Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine AND Order on Motion in Limine	Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”), 10,426,787 (“the ’787 patent,” and together…together with the ’895 patent, the “Combination Patents”), 8,809,307 (“the ’307 patent”) and 10,478,502 (…reduction . . .” (Claim 1 of the ‘787 patent; claim 1 of the ‘895 patent.) The language of the relevant…produces” test has a foundation in either the patents or patent law; this Court rejects Defendants’ argument…starring role in the patent specifications, as IDP-118 has in the Combination Patents. There is nothing	External link to document
2022-11-30	246	Opinion	Bausch owns U.S. Patent Nos. 10,251,895 (“the ’895 patent”), 10,426,787 (“the ’787 patent,” and together…the ’502 patent,” and together with the ’307 patent, the “HP Patents”). All four patents are listed…the ’295 patent; 2) Blum, the ’295 patent and the ’566 patent; and 3) Blum, the ’295 patent, and JP…together with the ’895 patent, the “Combination Patents”), 8,809,307 (“the ’307 patent”) and 10,478,502 … of the’895 and ’787 Patents. ’895 Patent, at 11:30–20:10; ’787 Patent, at 11:30–20:8.	External link to document
2021-10-06	75	Opinion	concerning the ’307 Patent, the ’502 Patent, U.S. Patent Nos. 10,251,895 (the “’895 Patent”) and 10,426,787…infringement of U.S. Patent Nos. 8,809,307 (the “’307 Patent”) and 10,478,502 (the “’502 Patent”) through Padagis…prosecution of a patent application has a duty of candor and good faith in dealing with the [Patent] Office, …and ’787 patents being declared invalid. Padagis therefore seeks a judgment that these patents are unenforceable… Bryhali, wherein Padagis alleged that these patents are invalid, unenforceable, and/or will not be	External link to document
2021-11-03	83	Order AND Opinion	owns U.S. Patent Nos. 8,809,307 (“the ’307 patent”), 10,478,502 (“the ’502 patent”), 10,251,895 (“the ’…intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history…claim 1 of the ‘895 patent and claim 1 of the ‘787 patent. Claim 1 of the ‘895 patent is representative…and 22 of the ‘307 patent and claim 1 of the ‘502 patent. Claim 1 of the ‘502 patent states: … ’895 patent”), and 10,426,787 (“the ’787 patent”). The parties seek claim construction of terms in	External link to document